Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of 0.215x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM98.51 Million ≈ $24.73 Million USD) by net assets (RM459.15 Million ≈ $115.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 7081 current and long-term liabilities for a breakdown of total debt and financial obligations.
Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
G-Tech Optoelectronics Corp
TW:3149
|
-0.031x |
|
Jinling Hotel Corp Ltd
SHG:601007
|
0.053x |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
-0.130x |
|
Beijing Hanjian Heshan Pipeline Co Ltd
SHG:603616
|
-0.110x |
|
HAXC Holdings (Beijing) Co. Ltd.
SHE:300928
|
N/A |
|
Guangdong Anjubao Digital Tech
SHE:300155
|
0.000x |
|
Optiemus Infracom Limited
NSE:OPTIEMUS
|
-0.066x |
|
Dongsung FineTec Co. Ltd
KQ:033500
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Pharmaniaga Bhd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | RM459.15 Million ≈ $115.28 Million |
RM-17.69 Million ≈ $-4.44 Million |
-0.039x | +86.82% |
| 2024-12-31 | RM-145.94 Million ≈ $-36.64 Million |
RM42.67 Million ≈ $10.71 Million |
-0.292x | -70.67% |
| 2023-12-31 | RM-274.09 Million ≈ $-68.81 Million |
RM46.95 Million ≈ $11.79 Million |
-0.171x | -141.92% |
| 2022-12-31 | RM-348.31 Million ≈ $-87.45 Million |
RM-142.34 Million ≈ $-35.74 Million |
0.409x | +400.12% |
| 2021-12-31 | RM470.44 Million ≈ $118.11 Million |
RM-64.06 Million ≈ $-16.08 Million |
-0.136x | -78.76% |
| 2020-12-31 | RM337.53 Million ≈ $84.74 Million |
RM-25.71 Million ≈ $-6.45 Million |
-0.076x | -113.56% |
| 2019-12-31 | RM337.85 Million ≈ $84.82 Million |
RM189.76 Million ≈ $47.64 Million |
0.562x | +449.59% |
| 2018-12-31 | RM509.34 Million ≈ $127.88 Million |
RM-81.83 Million ≈ $-20.55 Million |
-0.161x | -135.44% |
| 2017-12-31 | RM528.05 Million ≈ $132.57 Million |
RM239.41 Million ≈ $60.11 Million |
0.453x | +578.93% |
| 2016-12-31 | RM530.63 Million ≈ $133.22 Million |
RM35.44 Million ≈ $8.90 Million |
0.067x | +434.25% |
| 2015-12-31 | RM560.00 Million ≈ $140.60 Million |
RM7.00 Million ≈ $1.76 Million |
0.013x | -96.76% |
| 2014-12-31 | RM552.00 Million ≈ $138.59 Million |
RM213.00 Million ≈ $53.48 Million |
0.386x | -23.89% |
| 2013-12-31 | RM503.00 Million ≈ $126.29 Million |
RM255.00 Million ≈ $64.02 Million |
0.507x | +1355.27% |
| 2012-12-31 | RM488.00 Million ≈ $122.52 Million |
RM17.00 Million ≈ $4.27 Million |
0.035x | -- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more